Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Toronto - Delayed Quote CAD

Cardiol Therapeutics Inc. (CRDL.TO)

1.4900
-0.0100
(-0.67%)
At close: April 25 at 4:00:00 PM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
78.7600
--
Operating Expense
40,276.6510
40,276.6510
41,335.8780
38,743.5610
20,690.4610
Operating Income
-40,276.6510
-40,276.6510
-41,335.8780
-38,664.8010
-20,690.4610
Net Non Operating Interest Income Expense
1,193.3420
1,193.3420
1,237.6320
106.0010
76.5830
Other Income Expense
2,406.0100
2,406.0100
9,167.5990
6,920.5560
-27.0570
Pretax Income
-36,677.2990
-36,677.2990
-30,930.6470
-31,638.2440
-20,640.9350
Net Income Common Stockholders
-36,677.2990
-36,677.2990
-30,930.6470
-31,638.2440
-20,640.9350
Diluted NI Available to Com Stockholders
-36,677.2990
-36,677.2990
-30,930.6470
-31,638.2440
-20,640.9350
Basic EPS
-0.51
-0.51
-0.49
-0.73
-0.69
Diluted EPS
-0.51
-0.51
-0.49
-0.73
-0.69
Basic Average Shares
71,567.7550
71,567.7550
62,505.9820
43,222.8190
29,857.1360
Diluted Average Shares
71,567.7550
71,567.7550
62,505.9820
43,222.8190
29,857.1360
Total Expenses
40,276.6510
40,276.6510
41,335.8780
38,743.5610
20,690.4610
Net Income from Continuing & Discontinued Operation
-36,677.2990
-36,677.2990
-30,930.6470
-31,638.2440
-20,640.9350
Normalized Income
-39,055.0860
-39,055.0860
-39,933.8030
-38,446.5710
-20,606.4800
Interest Income
1,193.3420
1,193.3420
1,237.6320
106.0010
76.5830
Net Interest Income
1,193.3420
1,193.3420
1,237.6320
106.0010
76.5830
EBIT
-40,276.6510
-40,276.6510
-41,335.8780
-38,664.8010
-20,690.4610
EBITDA
-39,903.5370
-39,903.5370
-41,115.9700
-38,444.3800
-20,460.9220
Reconciled Depreciation
373.1140
373.1140
219.9080
220.4210
229.5390
Net Income from Continuing Operation Net Minority Interest
-36,677.2990
-36,677.2990
-30,930.6470
-31,638.2440
-20,640.9350
Total Unusual Items Excluding Goodwill
2,377.7870
2,377.7870
9,003.1560
6,808.3270
-34.4550
Total Unusual Items
2,377.7870
2,377.7870
9,003.1560
6,808.3270
-34.4550
Normalized EBITDA
-42,281.3240
-42,281.3240
-50,119.1260
-45,252.7070
-20,426.4670
12/31/2020 - 12/20/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MDP.TO Medexus Pharmaceuticals Inc.
2.7000
-2.53%
 
GHG.CN Global Hemp Group Inc.
0.0200
0.00%
 
DHB.V Delivra Health Brands Inc.
0.1800
+12.50%
 
BHC.TO Bausch Health Companies Inc.
7.53
-0.66%
 
TLRY.TO Tilray Brands, Inc.
0.6900
+1.47%
 
CL.CN Cresco Labs Inc.
1.1800
+7.27%
 
PLTH.CN Planet 13 Holdings Inc.
0.4000
+11.11%
 
AYR-A.CN Ayr Wellness Inc.
0.3250
0.00%
 
RDY Dr. Reddy's Laboratories Limited
13.79
-1.50%
 
LABS.TO MediPharm Labs Corp.
0.0900
0.00%